Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice
Clicks: 100
ID: 273537
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
4.5
/100
15 views
15 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
hESC-MSC restored structure and function in the cisplatin-damaged ovary. Our study provides new insights into the great clinical potential of human hESC-MSC in treating POF.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (25 words).
Try re-searching for a better abstract.
| Reference Key |
sy2020stemrecovery
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yoon SY;Yoon JA;Park M;Shin EY;Jung S;Lee JE;Eum JH;Song H;Lee DR;Lee WS;Lyu SW;; |
| Journal | stem cell research & therapy |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Mice
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
pmid:32586410
pmc7318510
doi:10.1186/s13287-020-01769-6
sook young yoon
jung ah yoon
sang woo lyu
cisplatin / toxicity
human embryonic stem cells*
mesenchymal stem cell transplantation*
mesenchymal stem cells*
primary ovarian insufficiency* / chemically induced
primary ovarian insufficiency* / therapy
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.